האגודה למלחמה בסרטן - במה - גיליון מס' 24 - אוגוסט 2021

רשימת ספרות

1. Minard-Colin V, Brugières L, Reiter A, et al. Non- hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015 Sep 20;33(27):2963-74. Epub 2015 Aug 24. 2. Dozzo M, Carobolante F, Donisi PM, et al. Burkitt lymphoma in adolescents and young adults: management challenges. Adolesc Health Med Ther. 2016 Dec 23;8:11-29. 3. Minard-Colin V, Aupérin A, Pillon M, et al. Rituximab for high-risk, mature B-cell non-Hodgkin’s lymphoma in children. N Engl J Med. 2020 Jun 4;382(23):2207-19. 4. Moleti ML, Testi AM, Foà R. Treatment of relapsed/ refractory paediatric aggressive B-cell non-Hodgkin lymphoma. Br J Haematol. 2020 Jun;189(5):826-43. Epub 2020 Mar 6. 5. Miles RR, Raphael M, McCarthy K, et al. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein

expression, and a high incidence of germinal center subtype: report of the French-American-British (FAB) international study group. Pediatr Blood Cancer. 2008 Sep;51(3):369-74. 6. Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):589–97. 7. Burkhardt B, Hermiston ML. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities. Br J Haematol. 2019 Jun;185(6):1158-70. Epub 2019 Feb 27. 8. Callens C, Baleydier F, Lengline E, et al. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol. 2012 Jun 2;30(16):1966-73. Epub 2012 Apr 30. 9. Eyre TA, Khan D, Hall GW, et al. Anaplastic lymphoma kinase-positive anaplastic large cell

lymphoma: current and future perspectives in adult and paediatric disease. Eur J Haematol. 2014 Dec;93(6):455-68. Epub 2014 May 21. 10. Brugières L, Pacquement H, Le Deley MC, et al. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol. 2009 Oct 20;27(30):5056-6. Epub 2009 Sep 8. 11. Le Deley MC, Rosolen A, Williams DM, et al. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial. J Clin Oncol. 2010 Sep 1;28(25):3987-93. Epub 2010 Aug 2. 12. Prokoph N, Larose H, Lim MS, et al. Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond. Cancers (Basel). 2018 Mar 30;10(4):99.

31